Commodore Capital reported a 3.9% stake in Viridian Therapeutics, Inc.\DE VRDN · 3,200,000 sh · amendment · passive holder

Trade details

Type: 5% stake report
Report: 13G passive · amendment
Stake: 3.9%
Last report: 5.3% · filed 25/04/11
Shares held: 3,200,000 sh
Class: Common Stock, $0.01 par value
Stock: Viridian Therapeutics, Inc.\DE VRDN
Holder: Commodore Capital
Event date: 25/09/30
Filed: 25/11/14

3.9% stake · below 5%

Stake: 3.9%
Last report: 5.3%
Since last report: −1.4pp

Viridian Therapeutics, Inc.\DE trades, last 26 weeks

What else happened in Viridian Therapeutics, Inc.\DE around then

Filed or reported within 30 days of the trade day · 25/08/31~25/10/30

Commodore Capital's other 5% stake reports

Commodore Capital
5% stakeJatt III Acquisition
5% stake
Jatt III Acquisition
JTTT
5.2% stake
400,000 sh
5.2% stake
Filed 09/02
Commodore Capital
5% stakeInflaRx
5% stake
InflaRx
IFRX
5.1% stake
7,475,000 sh
5.1% stake
Filed 08/17
Commodore Capital
5% stakePalisade Bio
5% stake
Palisade Bio
PALI
0% stake
0 sh
0% stake
Filed 08/14
Commodore Capital
5% stakeJatt II Acquisition
5% stake
Jatt II Acquisition
JATT
0% stake
0 sh
0% stake
Filed 08/14
Commodore Capital
5% stakeRelay Therapeutics
5% stake
Relay Therapeutics
RLAY
5.5% stake
12,000,000 sh
5.5% stake
Filed 08/14